| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | TESARO INC | 8,854,255 | 355,056,000 | 23.39% | ||
| 2 | ARDELYX INC COM | 10,294,096 | 177,882,000 | 11.72% | ||
| 3 | GROUPON INC | 44,172,953 | 144,004,000 | 9.49% | ||
| 4 | SUPERNUS PHARMACEUTICALS INC COM | 7,641,250 | 107,207,000 | 7.06% | ||
| 5 | CLOVIS ONCOLOGY INC | 1,139,890 | 104,824,000 | 6.91% | ||
| 6 | DERMIRA INC | 3,506,649 | 81,845,000 | 5.39% | ||
| 7 | OPOWER INC | 8,997,290 | 80,166,000 | 5.28% | ||
| 8 | EPIZYME INC COM | 5,149,740 | 66,226,000 | 4.36% | ||
| 9 | TREVENA INC | 4,811,691 | 49,801,000 | 3.28% | ||
| 10 | GLYCOMIMETICS INC | 8,575,135 | 48,021,000 | 3.16% | ||
| 11 | NEVRO CORP | 993,428 | 46,085,000 | 3.04% | ||
| 12 | LOXO ONCOLOGY INC COM | 1,792,207 | 31,328,000 | 2.06% | ||
| 13 | AEROHIVE NETWORKS INC | 4,681,455 | 27,995,000 | 1.84% | ||
| 14 | * LEXICON PHARMACEUTICALS INC COM | 2,382,286 | 25,586,000 | 1.69% | ||
| 15 | TRIVASCULAR TECHNOLOGIES INC | 3,945,191 | 19,726,000 | 1.30% | ||
| 16 | Tracon Pharmaceuticals Inc | 1,889,652 | 18,462,000 | 1.22% | ||
| 17 | CARE COM INC COM | 3,260,989 | 16,761,000 | 1.10% | ||
| 18 | MILLENNIAL MEDIA INC | 8,224,752 | 14,393,000 | 0.95% | ||
| 19 | EXELIXIS INC | 2,207,000 | 12,381,000 | 0.82% | ||
| 20 | Zosano Pharma Corp | 2,158,543 | 8,548,000 | 0.56% | ||
| 21 | CHAMPIONS ONCOLOGY INC | 1,562,500 | 8,359,000 | 0.55% | ||
| 22 | CVENT INC | 244,106 | 8,217,000 | 0.54% | ||
| 23 | RIGEL PHARMACEUTICAL INC | 3,243,150 | 8,011,000 | 0.53% | ||
| 24 | Orexigen Therapeutics, Inc. | 3,709,000 | 7,826,000 | 0.52% | ||
| 25 | ARCA BIOPHARMA INCORPORATED COM PAR .001 | 1,460,209 | 7,243,000 | 0.48% | ||
| 26 | AURINIA PHARMACEUTICALS INC | 2,546,843 | 7,233,000 | 0.48% | ||
| 27 | ZHONE TECHNOLOGIES INC NEW | 4,781,290 | 6,550,000 | 0.43% | ||
| 28 | ROKA BIOSCIENCE INC | 3,220,433 | 6,280,000 | 0.41% | ||
| 29 | CHANNELADVISOR CORP COM | 556,692 | 5,534,000 | 0.36% | ||
| 30 | ArQule Inc | 2,520,316 | 4,713,000 | 0.31% | ||
| 31 | Sunesis Pharmaceuticals I | 5,689,644 | 4,609,000 | 0.30% | ||
| 32 | Catalyst Biosciences | 652,380 | 3,040,000 | 0.20% | ||
| 33 | PARATEK PHARMACEUTICALS INC | 125,004 | 2,375,000 | 0.16% | ||
| 34 | Agile Therapeutics, Inc. | 133,488 | 900,000 | 0.06% | ||
| 35 | AKARI THERAPEUTICS PLC | 26,894 | 645,000 | 0.04% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001512848-15-000005, filed 2015.11.10).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
